145 related articles for article (PubMed ID: 24803897)
1. Durable response of human epidermal growth factor receptor-2-positive gastric adenosquamous carcinoma to trastuzumab-based chemotherapy.
Kadowaki S; Yatabe Y; Nitta S; Ito Y; Muro K
Case Rep Oncol; 2014 Jan; 7(1):210-6. PubMed ID: 24803897
[TBL] [Abstract][Full Text] [Related]
2. Complete Response to Trastuzumab-Based Chemotherapy in a Patient with Human Epidermal Growth Factor Receptor-2-Positive Metastatic Salivary Duct Carcinoma ex Pleomorphic Adenoma.
Kadowaki S; Yatabe Y; Hirakawa H; Komori A; Kondoh C; Hasegawa Y; Muro K
Case Rep Oncol; 2013; 6(3):450-5. PubMed ID: 24163659
[TBL] [Abstract][Full Text] [Related]
3. A Phase II Study of the Combination of Oxaliplatin, Capecitabine, and Trastuzumab and Chemoradiotherapy in the Adjuvant Setting in Operated Patients With HER2-positive Gastric or Gastroesophageal Junction Cancer (TOXAG Study): A Turkish Oncology Group Study.
Abali H; Yalcin S; Onal HC; Dane F; Oksuzoglu B; Ozdemir N; Mertsoylu H; Artac M; Camci C; Karabulut B; Basal FB; Budakoglu B; Sendur MAN; Goktas B; Ozdener F; Baygul A
Am J Clin Oncol; 2021 Jul; 44(7):301-307. PubMed ID: 33979100
[TBL] [Abstract][Full Text] [Related]
4. Mixed adenoneuroendocrine carcinoma with loss of HER2 positivity after trastuzumab-based chemotherapy for HER2-positive gastric cancer: a case report.
Nagata H; Tsujimoto H; Yaguchi Y; Kouzu K; Itazaki Y; Ishibashi Y; Tsuchiya S; Sugihara T; Ito N; Harada M; Nomura S; Utsumi Y; Shimazaki H; Kishi Y; Ueno H
Surg Case Rep; 2020 Jan; 6(1):5. PubMed ID: 31916037
[TBL] [Abstract][Full Text] [Related]
5. [Hepatic Resection of Multiple Liver Metastases from Gastric Cancer after Molecular Targeted Chemotherapy(S-1 plus Cisplatin plus Trastuzumab)].
Kim Y; Hosoda Y; Nishino M; Okano M; Kawada J; Yamasaki M; Nagai K; Yasui M; Okuyama M; Tsujinaka T
Gan To Kagaku Ryoho; 2015 Nov; 42(12):1635-7. PubMed ID: 26805121
[TBL] [Abstract][Full Text] [Related]
6. [A Case of HER2-Positive Advanced Gastric Cancer with Multiple Liver Metastases Effectively Treated with Trastuzumab, Capecitabine, and Cisplatin Combination Therapy].
Kuga Y; Kitamura S; Okanobu H; Sakimoto H; Nishida T
Gan To Kagaku Ryoho; 2016 Oct; 43(10):1211-1214. PubMed ID: 27760940
[TBL] [Abstract][Full Text] [Related]
7. [A Case of HER2-Positive Stage IV Advanced Gastric Cancer Treated with Chemotherapy Combined with Trastuzumab].
Takaya K; Takahashi R; Honma S; Horii S; Takahashi H; Hagiwara M; Chin M; Hashizume E
Gan To Kagaku Ryoho; 2016 Sep; 43(9):1113-6. PubMed ID: 27628555
[TBL] [Abstract][Full Text] [Related]
8. [A case of HER2-positive advanced gastric cancer successfully treated with a combination of capecitabine, cisplatin, and trastuzumab as first-line chemotherapy].
Deguchi K; Nishikawa K; Iwase K; Kawada J; Aono T; Yoshida H; Nomura M; Tamagawa H; Matsuda C; Deguchi T; Higashi S; Okumura Y; Noguchi Y; Nomura M; Takagi M; Fukui A; Tanaka Y
Gan To Kagaku Ryoho; 2013 Nov; 40(12):2253-5. PubMed ID: 24394076
[TBL] [Abstract][Full Text] [Related]
9. EORTC-1203-GITCG - the "INNOVATION"-trial: Effect of chemotherapy alone versus chemotherapy plus trastuzumab, versus chemotherapy plus trastuzumab plus pertuzumab, in the perioperative treatment of HER2 positive, gastric and gastroesophageal junction adenocarcinoma on pathologic response rate: a randomized phase II-intergroup trial of the EORTC-Gastrointestinal Tract Cancer Group, Korean Cancer Study Group and Dutch Upper GI-Cancer group.
Wagner AD; Grabsch HI; Mauer M; Marreaud S; Caballero C; Thuss-Patience P; Mueller L; Elme A; Moehler MH; Martens U; Kang YK; Rha SY; Cats A; Tokunaga M; Lordick F
BMC Cancer; 2019 May; 19(1):494. PubMed ID: 31126258
[TBL] [Abstract][Full Text] [Related]
10. [A Case of Advanced Gastric Cancer with Multiple Liver Metastases Successfully Treated with Capecitabine, Cisplatin, and Trastuzumab].
Oneda Y; Tamura S; Murakami K; Takeno A; Kuwahara R; Akiyama Y; Sakamoto T; Inatome J; Naito A; Katsura Y; Ohmura Y; Kagawa Y; Egawa C; Takeda Y; Kato T
Gan To Kagaku Ryoho; 2016 Nov; 43(12):2202-2204. PubMed ID: 28133269
[TBL] [Abstract][Full Text] [Related]
11. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial.
Bang YJ; Van Cutsem E; Feyereislova A; Chung HC; Shen L; Sawaki A; Lordick F; Ohtsu A; Omuro Y; Satoh T; Aprile G; Kulikov E; Hill J; Lehle M; Rüschoff J; Kang YK;
Lancet; 2010 Aug; 376(9742):687-97. PubMed ID: 20728210
[TBL] [Abstract][Full Text] [Related]
12. Optimal regimen of trastuzumab in combination with oxaliplatin/ capecitabine in first-line treatment of HER2-positive advanced gastric cancer (CGOG1001): a multicenter, phase II trial.
Gong J; Liu T; Fan Q; Bai L; Bi F; Qin S; Wang J; Xu N; Cheng Y; Bai Y; Liu W; Wang L; Shen L
BMC Cancer; 2016 Feb; 16():68. PubMed ID: 26857702
[TBL] [Abstract][Full Text] [Related]
13. [A Case of Hepatic Resection after Neoadjuvant Chemotherapy for Single Liver Metastasis from Gastric Cancer with Positive Human Epidermal Growth Factor Receptor 2].
Nagae A; Nishikawa K; Maeda S; Hamakawa T; Hirao M; Uemura M; Miyake M; Hama N; Miyamoto A; Miyazaki M; Kato T; Sekimoto M
Gan To Kagaku Ryoho; 2018 Dec; 45(13):2423-2425. PubMed ID: 30692485
[TBL] [Abstract][Full Text] [Related]
14. Discordances in HER2 status between primary gastric cancer and corresponding metastatic sites.
Gumusay O; Benekli M; Ekinci O; Baykara M; Ozet A; Coskun U; Demirci U; Uner A; Dursun A; Atak EY; Buyukberber S
Jpn J Clin Oncol; 2015 May; 45(5):416-21. PubMed ID: 25732909
[TBL] [Abstract][Full Text] [Related]
15. [A case report of neuroendocrine carcinoma of the stomach with liver metastases curatively resected after neoadjuvant chemotherapy].
Hokonohara K; Takata A; Noda T; Imamura H; Hirota M; Oshima K; Tanida T; Hatano H; Komori T; Morita S; Iwazawa T; Akagi K; Adachi S; Dono K
Gan To Kagaku Ryoho; 2014 Nov; 41(12):2287-9. PubMed ID: 25731498
[TBL] [Abstract][Full Text] [Related]
16. Clinical Practice Observation of Trastuzumab in Patients with Human Epidermal Growth Receptor 2-Positive Metastatic Adenocarcinoma of the Stomach or Gastroesophageal Junction.
Al-Batran SE; Moorahrend E; Maintz C; Goetze TO; Hempel D; Thuss-Patience P; Gaillard VE; Hegewisch-Becker S
Oncologist; 2020 Aug; 25(8):e1181-e1187. PubMed ID: 32311799
[TBL] [Abstract][Full Text] [Related]
17. Surgical resection of advanced gastric cancer following trastuzumab/oxaliplatin/capecitabine combination therapy.
Dong CX; Fu JF; Ye XY; Li XF; Zhong X; Yuan Y
World J Gastroenterol; 2014 Sep; 20(34):12355-8. PubMed ID: 25232273
[TBL] [Abstract][Full Text] [Related]
18. Trastuzumab-Based Combination Chemotherapy in Patients with Human Epidermal Growth Factor Receptor-2-Positive Metastatic Carcinoma ex Pleomorphic Adenoma.
Arihara Y; Murase K; Takada K; Hayasaka N; Miura S; Miyanishi K; Kobune M; Kurose M; Akiyama Y; Sugita S; Kato J
Case Rep Oncol; 2018; 11(3):835-841. PubMed ID: 30687059
[TBL] [Abstract][Full Text] [Related]
19. [A case of HER2-positive advanced gastric cancer successfully treated via capecitabine, cisplatin, and trastuzumab combination chemotherapy].
Endo S; Yamada T; Okuyama M; Hiraoka K; Konishi K; Kim C; Nakagawa T; Takeda K; Ueda Y; Matsumoto K; Nishikawa K; Nishijima J
Gan To Kagaku Ryoho; 2015 Mar; 42(3):359-61. PubMed ID: 25812508
[TBL] [Abstract][Full Text] [Related]
20. Role of human epidermal growth factor receptor 2 in gastric cancer: biological and pharmacological aspects.
Jørgensen JT
World J Gastroenterol; 2014 Apr; 20(16):4526-35. PubMed ID: 24782605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
